[HTML][HTML] A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors

D Kang, S Liu, X Yuan, S Liu, Z Zhang, Z He… - Journal of Cancer …, 2023 - Springer
Introduction Tumor immunotherapy has recently emerged as a crucial focal point in
oncology treatment research. Among tumor immunotherapy approaches, tumor immune …

PD-L1 expression and survival rates using TPS and CPS for nivolumab-treated head-and-neck cancer

T Ito, I Okamoto, K Tokashiki, H Sato… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: This study investigated the expression and survival rates of programmed
cell death ligand 1 using the tumor proportion score (TPS) and combined positive score …

Real-world experience with pembrolizumab for advanced-stage head and neck cancer patients: a retrospective, multicenter study

T Nakano, R Yasumatsu, K Hashimoto… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: This study investigated the effectiveness of pembrolizumab with or without
chemotherapy on advanced-stage head and neck cancer (HNC), including nasopharyngeal …

Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma

H Hirai, M Nakaguro, Y Tada, N Saigusa, D Kawakita… - Virchows Archiv, 2023 - Springer
Salivary duct carcinoma (SDC) is an aggressive type of salivary gland carcinoma. Recently,
immunotherapies targeting immune checkpoints, including PD1, PD-L1, CTLA4, and LAG3 …

[BOOK][B] Evaluation der PD-L1-Expression und der Immunzellinfiltration sowie Untersuchung der prognostischen Relevanz beim Azinuszellkarzinom der …

S Hiß - 2023 - search.proquest.com
Methoden In dieser retrospektiven Untersuchung wurden Gewebeproben des Primärtumors
von 36 Patienten mit einem Azinuszellkarzinom und klinischen Langzeitdaten in Bezug auf …

再発・転移頭頸部癌

安松隆治 - 口腔・咽頭科, 2022 - jstage.jst.go.jp
再発・転移頭頸部癌 Page 1 123 口 咽 科 2022; 35(2):123 ~ 128 総説 再発・転移頭頸部癌 安松
隆治 九州大学医学研究院耳鼻咽喉科学分野 頭頸部癌では一次治療開始時に進行している割合が …